Assessing dose contribution to pelvic lymph nodes in intracavitary brachytherapy for cervical cancer

PURPOSE: In radical radiotherapy for cervical cancer, high-dose-rate (HDR) brachytherapy is commonly used after external beam radiation therapy (EBRT) to deliver a cumulative EQD(2) of 80 to 90 Gy to the primary tumor. However, there is less certainty regarding brachytherapy dose contribution to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chua, Gail Wan Ying, Foo, Yong Wee, Tay, Guan Heng, Tan, David Boon Harn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2017
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611454/
https://www.ncbi.nlm.nih.gov/pubmed/28951754
http://dx.doi.org/10.5114/jcb.2017.69237

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611454/
https://www.ncbi.nlm.nih.gov/pubmed/28951754
http://dx.doi.org/10.5114/jcb.2017.69237

Ejemplares similares